Federal contractor · PRINCETON, NJ

ENALARE THERAPEUTICS INC

ENALARE THERAPEUTICS INC received $810.1K in federal contract obligations in FY2026, on 1 awards. Since FY2021: $13M. Its largest customer was Office of Assistant Secretary for Preparedness and Response ($810.1K).

Obligations · FY2026
$810.1K
New awards
1
Sole-source
0.0%
Single offer
100%
UEI
MDJFW877BCV6
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 749KFY2021
  2. 6MFY2022
  3. 469.3KFY2023
  4. 5MFY2024
  5. 810.1KFY2026

Top buying agencies

Obligations in FY2026.

  1. Office of Assistant Secretary for Preparedness and Response$810.1K100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$810.1K100%

Where the work was performed

  1. Mercer County, NJ$810.1K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $810.1K
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions100%
    US 8.7% · $810.1K
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. ENALARE THERAPEUTICS: AN AGNOSTIC RESPIRATORY STIMULANT FOR USE AS A MEDICAL COUNTERMEASURE TO TREAT RESPIRATORY DEPRESSION$12.2M
    Office of Assistant Secretary for Preparedness and Response· Mercer County, NJ· Research & development· Sep 22, 2022 – May 18, 2026· 75A50122C00072

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

ENALARE THERAPEUTICS INC received $0 in federal assistance in FY2026, on 1 actions (0 new awards), −100% vs FY2025.

Assistance · FY2026
$0
New awards
0
Actions
1
Since FY2022
$2.8M

Assistance by fiscal year

  1. 319.7KFY2022
  2. 2.5MFY2025
  3. 0FY2026

Largest awards

  1. DEVELOPMENT OF MEDICATION FOR THE TREATMENT OF RESPIRATORY DEPRESSION DUE TO OPIOID (PRESCRIBED OR ILLICIT) OVERDOSE/MULTIDRUG…$2.8M
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Project grant· Jun 16, 2022 – Jun 23, 2026· R44DA057133

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2022–FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. VENATORX PHARMACEUTICALS INC$5.9M
    MALVERN, PA · 100% of this company's obligations are in markets they both serveOffice of Assistant Secretary for Preparedness and Response · Scientific research and development services
  2. AD ASTRA DIAGNOSTICS, INC.$6.7M
    MORRISVILLE, NC · 100% of this company's obligations are in markets they both serveOffice of Assistant Secretary for Preparedness and Response · Scientific research and development services
  3. TEXAS BIOMEDICAL RESEARCH INSTITUTE$4.8M−96% in FY2026
    SAN ANTONIO, TX · 82% of this company's obligations are in markets they both serveOffice of Assistant Secretary for Preparedness and Response · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

  • Enalare Therapeutics, Inc.AI match · 100%
Lobbying · 2023
$0
2 reports

Lobbying by year

  1. 2023$0
    2 reports

Top issues

Who was contacted

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

  1. American Defense International, Inc.$0
    2 reports

Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Oct 5, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.